Chinese biological drug developer Sinocelltech Group Limited is targeting to raise 1.28 billion yuan ($181 million) in its initial public offering on the Nasdaq-style STAR Market of the Shanghai Stock Exchange (SSE), according to the company’s latest filing on June 15.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
